Bio-Rad Labs (BIO) Issues Q3 EPS of $1.61, Beats by 8c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $382.41 +0.89%
Revenue Growth %: -0.4%
Financial Fact:
Net income including noncontrolling interests: 0
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: -0.4%
Financial Fact:
Net income including noncontrolling interests: 0
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q3 EPS of $1.61, $0.08 better than the analyst estimate of $1.53. Revenue for the quarter came in at $516.5 million versus the consensus estimate of $511.47 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bio-Rad to Participate in Fireside Chat During Bernstein Insights Healthcare Leaders and Disruptors 3rd Annual Forum
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- LuxExperience B.V. (LUXE) Misses Q2 EPS by 11c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
